Corporate Banner
Satellite Banner
Technology Networks Header
Friday, December 19, 2014
Technology Networks
 
Register | Sign in
Home Page>Products
  Product News
Bio-Rad Launches Easy-to-Use PureBlu™ Nuclear Staining Dyes
Tuesday, December 16, 2014
High purity, pre-aliquoted formulations for cell imaging experiments.

Highly Efficient Neuro Transfection Reagent
Friday, December 12, 2014
DNA-In™ Neuro from AMSBIO offers a cost effective, robust and easy-to-use DNA delivery solution.

Highly Versatile Single Tube Code Reader
Friday, December 05, 2014
The Tracxer TS201 MINI designed to enhance users lab space.

Consistent Embryoid Body Formation and Differentiation from Stem Cells
Tuesday, December 02, 2014
Cultrex® Embryoid Body Formation Kit from AMSBIO.

Ultra Low Temperature Rack for Tissue Storage Tubes
Monday, November 24, 2014
Micronic launch new new ultra-low temperature rack for tissue tube storage.

VivaFix™ Cell Viability Assays Launched
Monday, November 24, 2014
Bio-Rad introduces a simple way to assess the viability of cells for flow cytometry and cell sorting that is compatible with fixation.

Bio-Rad Launches Benchtop S3e™ Cell Sorter with AutoGimbal™ Nozzle Alignment System
Thursday, November 20, 2014
Walk-away automation for accurate and reliable cell sorts of one or two populations.

Irvine Scientific Introduces DMSO-Free
Wednesday, November 19, 2014
A chemically-defined cryopreservation solution for mesenchymal stem cells.

PRIME-XV® FreezIS DMSO-Free Launched
Tuesday, November 18, 2014
Irvine Scientific introduces DMSO-Free, chemically-defined cryopreservation solution for mesenchymal stem cells.

<< 1 2 3 4 5 6 7 >>
Showing Results 1 - 10 of 496
Scientific News
Dutch Public-Private Partnership Invests 28 Million Euro on Research into Personalized Medicine
The Netherlands' three Top Institutes for life-science research announce a joint research target to bring personalized medicine closer to reality.
FDA Grants Orphan Drug Status for Quark's QPI-1002 for the Prophylaxis of DGF in Kidney Transplant Patients
Company completes enrollment and dosing in the dose-escalation safety portion of a Phase 1/2 study.
Oncolytics Biotech® Receives MHRA Approval to Conduct Phase 3 Trial for REOLYSIN®
Conducting the trials in U.S. and Europe will allow Company to access the physicians that have worked with REOLYSIN in head and neck cancers.
Shenogen and Chemizon Announce Drug Discovery Collaboration Focused on Oncology and Endocrine Disorders
The agreement will create small molecule therapeutics targeting modulators of the ER-alpha 36 receptor.
Dutch Public-Private Partnership Invests 28 Million Euro on Research into Personalized Medicine
The Netherlands' three Top Institutes for life-science research announce a joint research target to bring personalized medicine closer to reality.
FDA Grants Orphan Drug Status for Quark's QPI-1002 for the Prophylaxis of DGF in Kidney Transplant Patients
Company completes enrollment and dosing in the dose-escalation safety portion of a Phase 1/2 study.
Oncolytics Biotech® Receives MHRA Approval to Conduct Phase 3 Trial for REOLYSIN®
Conducting the trials in U.S. and Europe will allow Company to access the physicians that have worked with REOLYSIN in head and neck cancers.
Skyscraper Banner
SELECTBIO Market Reports
LabTube - Videos for the Scientific Community
eposters - The Online Journal of Scientific Posters
Follow TechNetcom1 on Twitter
Technology Networks Ltd. on LinkedIn